| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/19/2006 | EP1436005A4 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 04/19/2006 | EP1423363B1 Oral antidiabetic agents |
| 04/19/2006 | EP1420784B1 Compounds effecting glucokinase |
| 04/19/2006 | EP1409001B1 Mineral-protein preparations (mpp) and neuropathies in diabetes |
| 04/19/2006 | EP1370559B1 Triazolopyridines as anti-inflammatory agents |
| 04/19/2006 | EP1349833B1 Indole and dihydroindole derivatives |
| 04/19/2006 | EP1317428B1 Pyrrolidine-2-carboxylic acid hydrazide derivatives for use as metalloprotease inhibitors |
| 04/19/2006 | EP1299102B1 Use of riluzole or its salts for preventing and treating adrenoleukodystrophy |
| 04/19/2006 | EP1294724B1 Pyrrolo¬2,3-d|pyrimidine compounds as immunosuppressive agents |
| 04/19/2006 | EP1259125B1 Inulin products with improved nutritional properties |
| 04/19/2006 | EP1255452B1 A method for maintaining or improving the synthesis of mucins |
| 04/19/2006 | EP1250350B1 Novel crystalline composites comprising phytosterols and phytostanols or derivatives thereof |
| 04/19/2006 | EP1237886B1 Meglumine salt of a specific quinolinecarboxylic acid compound active on nmda receptors |
| 04/19/2006 | EP1196167B1 Use of p38 MAPK inhibitors in the treatment of ophthalmic conditions |
| 04/19/2006 | EP1189890B1 Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 04/19/2006 | EP1177176B1 Tri-aryl acid derivatives as ppar receptor ligands |
| 04/19/2006 | EP1151102B1 Glycosylated leptin compositions and related methods |
| 04/19/2006 | EP1080726B1 Agents for relieving side effects |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | EP1039934B1 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/19/2006 | CN1761680A Metastin derivative and use thereof |
| 04/19/2006 | CN1761676A Heteroaryl 5-thio-beta-d-glucopyranoside derivatives and remedies for diabetes containing the same |
| 04/19/2006 | CN1761664A Immunomodulating heterocyclic compounds |
| 04/19/2006 | CN1761479A Use of low molecular weight thrombin inhibitors in cholesterol-lowering therapy |
| 04/19/2006 | CN1761465A Method for manufacturing coated formulation |
| 04/19/2006 | CN1760210A Fusion protein possessing function of weight reduction, coded gene and application |
| 04/19/2006 | CN1760205A Mutant of ciliary nerves trophic factor (CNTF), producing method and usage |
| 04/19/2006 | CN1760172A Tetra-(alpha-amino-acid or dipeptide) complexes of di-copper and synthetic method, and SOD loke activity |
| 04/19/2006 | CN1759883A Composition of natural products for curing or preventing hyperlipemia and related disease |
| 04/19/2006 | CN1759861A Recipe of drop pills of compound selfheal spike, and preparation method |
| 04/19/2006 | CN1759856A Compound preparation of multi-metalloidlothioneins and intrinsic biological active matter of earthworm |
| 04/19/2006 | CN1759851A Preparation for enriching calcium, and preparation method |
| 04/19/2006 | CN1759843A Application of astragaloside in preparing medication for treating peripheral nervous lesion of diabetes |
| 04/19/2006 | CN1759834A Application of berberine or associated with Simvastatin in preparing product for preventing or curing disease or symptom related to blood fat |
| 04/19/2006 | CN1759825A Effervescence tablet containing multiplex vitamin including iron, zinc and calcium, ring shaped preparation, and preparation method |
| 04/19/2006 | CN1759741A Nutrient solution strengthening the body of children, and preparation method |
| 04/19/2006 | CN1759729A Production of sanitary battercake of ginseng and preparation method |
| 04/19/2006 | CN1759709A Method for preparing health care beverage |
| 04/19/2006 | CN1252071C Xanthine Phosphodiesterase V inhibitors |
| 04/19/2006 | CN1252065C Cinnoline compounds |
| 04/19/2006 | CN1252060C Sugarapple plant extract with action of resisting diabetes, medicinal application and preparation method |
| 04/19/2006 | CN1252057C Thiazole derivatives for treating PPAR related disorders |
| 04/19/2006 | CN1252040C Novel aryl, alkenyl and alkynl 4-dedimethylamino tetracycline derivatives |
| 04/19/2006 | CN1251728C Medicine for treating diabets mellitus and preparing process thereof |
| 04/19/2006 | CN1251706C Prepared traditional Chinese medicine for treating diabetes |
| 04/19/2006 | CN1251703C Soft capsule made of walnut oil for taking care of brain health |
| 04/19/2006 | CN1251693C Chinese-western medicine compound preparation and its preparing method |
| 04/19/2006 | CN1251685C Honey-based biological selenium conversion method |
| 04/19/2006 | CN1251681C Highly concentration water-soluble vitamin for intravenous injection and preparation and use |
| 04/19/2006 | CN1251620C Multifunctional fat reducing nutrition drink |
| 04/18/2006 | US7030251 Modifications of the trometamol salt of R-thioctic acid as well as a process for their production |
| 04/18/2006 | US7030242 Selective inhibition of aggrecanase in osteoarthritis treatment |
| 04/18/2006 | US7030222 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 04/18/2006 | US7030160 An agonist as beta-3 adrenergic receptors; chemical intermediates preparing through decyclization, hydroxylation; for treating gastrointestinal diseases, obesity, diabetics, psychotropic agents, nervous system disorders |
| 04/18/2006 | US7030151 Micronized amorphous form for better bioavailability; hypercholesterolemia, hyperlipidemia |
| 04/18/2006 | US7030143 Heterocyclic compounds |
| 04/18/2006 | US7030141 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 04/18/2006 | US7030135 A sulfonylamino-tetrahydro(1,3)thiazolo(5,4-c)pyridinyl or benzothiazole derivatives, for treating diabetes, syndrome X, obesity, glaucoma, hyperlipidemia, hyperglycemia, hyperinsulinemia, osteoporosis, tuberculosis, dementia |
| 04/18/2006 | US7030133 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 04/18/2006 | US7030123 Indole derivatives with vascular damaging activity |
| 04/18/2006 | US7030120 Nitrogen-containing heterocyclic compounds and benzamide compounds and drugs containing the same |
| 04/18/2006 | US7030113 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/18/2006 | US7030106 Ezetimibe formulation with lactose, croscarmellose sodium, povidone, sodium lauryl sulfate, magnesium stearate and microcrystalline cellulose |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029898 Comprises chimeric polypeptide with hydrolase and mitogen activated protein kinase activity for diagnosis and treatment of cell proliferation and differentiation disorders |
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/13/2006 | WO2006039334A1 Combinations of substituted azetidonones and cb1 antagonists |
| 04/13/2006 | WO2006039256A1 Use of gpr103 agonists for modulating feeding behaviour |
| 04/13/2006 | WO2006038865A1 Nucleotide derivatives for the treatment of type 2 diabetes and other disorders |
| 04/13/2006 | WO2006038738A1 Receptor function regulating agent |
| 04/13/2006 | WO2006038680A1 2-arylcarboxamide-nitrogeneous heterocycle compound |
| 04/13/2006 | WO2006038613A1 Oral composition containing difructose anhydride |
| 04/13/2006 | WO2006037789A1 A pharmaceutical formulation comprising crystalline insulin and dissolved insulin |
| 04/13/2006 | WO2006037348A1 Pharmaceutical compositions comprising fenofibrate and a statin |
| 04/13/2006 | WO2006037347A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 04/13/2006 | WO2006037346A1 Pharmaceutical compositions comprising fenofibrate and simvastatin |
| 04/13/2006 | WO2006037345A1 Pharmaceutical composition comprising fenofibrate and simvastatin |
| 04/13/2006 | WO2006037344A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 04/13/2006 | WO2006018185A3 Dihydropteridinones for the treatment of cancer diseases |
| 04/13/2006 | WO2006010546A3 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
| 04/13/2006 | WO2005105066A8 Histone deacetylases inhibitors against hyperlipidaemias, atherosclerosis, cardiovascular diseases |
| 04/13/2006 | US20060079707 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 04/13/2006 | US20060079692 Synthesis of indole thiazole compounds as ligands for the Ah receptor |
| 04/13/2006 | US20060079688 Process for producing acid adduct salt of polyacidic base compound |
| 04/13/2006 | US20060079565 Amino acid composition and supplementary liquid containing the same |
| 04/13/2006 | US20060079553 Quinoline derivatives as glucokinase ligands |
| 04/13/2006 | US20060079549 Administering a stimulantfor the endogenous production/ release of somatotropins; 3-((1-(2-aminoprop-2-yl)carbonylamino-),2-(phenylmethoxymethyl-)ethyl-),5-(morpholino-carbonyloxymethyl-)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-)pyridine; osteoporosis; obesity;improving bone densisty, muscle mass/strength |
| 04/13/2006 | US20060079548 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 04/13/2006 | US20060079540 Pde4 and pde3/4 inhibitors for use in the treatment of cachexia |
| 04/13/2006 | US20060079525 antiinflammatory agent N-{[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}cyclopropane carboxamide; bronchitis, asthma, chronic obstructive pulmonary disease and rhinitis |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/13/2006 | US20060079490 Method of treatment of type I diabetes |
| 04/13/2006 | US20060079452 Administering anakinra |
| 04/13/2006 | US20060078956 Methods to identify compounds that modulate rage |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078595 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 04/13/2006 | US20060078582 Use of compositions for treating rosacea |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | CA2583326A1 Receptor function regulating agent |
| 04/13/2006 | CA2582405A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |